Viracta Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Viracta Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2022.
  • Viracta Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2022 was $100K, a 66.7% decline year-over-year.
  • Viracta Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2022 was $209K.
  • Viracta Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $546K, a 59.2% increase from 2020.
  • Viracta Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $343K, a 42.8% decline from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $209K $100K -$200K -66.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $409K $104K -$143K -57.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $552K $105K +$6K +6.06% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $546K -$100K +$55.4M +99.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-17
Q3 2021 -$54.9M $300K +$223K +290% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$55.1M $247K +$139K +129% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$55.2M $99K -$55.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $343K -$55.5M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $77K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $108K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $55.7M* +$55.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $100K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.